Dr. Struck's research focuses on retinal function in albinism, particularly on the halted anatomical development and resulting visual impairment.
Ms. Plasil has a background in animal and human biology with core medical laboratory experience and over a decade of practice in ophthalmology. Within OSOD, she is skilled at working with multiple animal species including non-human primates, canines, rodents, and rabbits. Having proficiency with a variety of diagnostic systems, her multiple data acquisition roles include electrophysiological testing, ultrasound pachymetry, corneal confocal microscopy, as well as retinal imaging OCT and anterior segment OCT. Ms.
Dr. Park is a board certified veterinary ophthalmologist and Assistant Professor at the College of Veterinary Medicine, at Purdue University. Her clinical and research interests include glaucoma and ocular Imaging
Ms. Newman serves as a regulatory affairs expert consulting on many ophthalmology programs creating development strategies for small molecules, biologics, devices and gene/cell therapies. Her deep experience helps clients to navigate regulatory requirements for US FDA and EU EMEA submissions for clinical studies, global regulatory authority meetings and product registration. Most recently, Ms.
Dr. Kim is an assistant professor at the School of Veterinary Medicine, University of California-Davis, specializing in comparative ophthalmology. Her research interests include corneal wound healing, the ocular toxicity of metallic-engineered nanomaterials, and advanced ophthalmic imaging techniques. She is particularly interested in utilizing advanced imaging techniques, such as optical coherence tomography for serial retinal and choroidal imaging, ultrasound biomicroscopy, and in vivo confocal biomicroscopy, to monitor various ophthalmic disease conditions in animals.
Dr. Good is a board-certified veterinary ophthalmologist and Clinical Professor of Veterinary Ophthalmology at the UC Davis School of Veterinary Medicine. She spent 6 years in private ophthalmology practice before joining the faculty at UC Davis in 2008. She has published in several veterinary scientific journals and is actively involved in clinical ophthalmic research. Her clinical and research interests include glaucoma, dry eye, and ocular manifestations of systemic disease.
Dr. Christian is a regulatory toxicologist with over 30 years of experience in the contract pharmaceutical research industry. Prior to joining OSOD he served as the scientific lead for the ocular toxicology services offered at Covance/Labcorp Laboratories which included planning and directing nonclinical toxicology and pharmacology studies as senior study director. Brian is a diplomate of the American Board of Toxicology and has served on the Executive Committee of the Ocular Toxicology Specialty Section of the Society of Toxicology.
Dr. Cherry is Professor in the Department of Biomedical Engineering and Director of the Center for Molecular and Genomic Imaging at the University of California, Davis. Dr. Cherry’s research interests center around biomedical imaging and in particular the development and application of in vivo molecular imaging technology and systems, with specific expertise in positron emission tomography (PET) and optical imaging and their application in preclinical research.
Dr. Brandt is a Professor in the Departments of Ophthalmology and Visual Sciences, Medical Microbiology and Immunology, and the Clinical Cancer Center at the University of Wisconsin-Madison. His primary research interest is virology, specifically pathogenesis of herpes simplex virus; virulence genes in herpetic eye disease and herpes encephalitis; antivirals; interactions between cytokines and herpes viruses, gene delivery, and gene therapy.